Table 1.
Patient characteristics.
| Characteristic* | AA N = 88 (71%) | Caucasian N = 36 (29%) | Total N = 124 (100%) | P-value |
|---|---|---|---|---|
| Age groups | ||||
| <50 | 44 (50) | 11 (31) | 55 (44) | 0.07 |
| ≥50 | 44 (50) | 25 (69) | 69 (56) | |
| Menopausal status | ||||
| Post | 53 (60) | 27 (75) | 80 (65) | 0.15 |
| Pre | 35 (40) | 9 (25) | 44 (35) | |
| Nodal status | ||||
| Negative | 41 (47) | 23 (64) | 64 (52) | 0.11 |
| Positive | 46 (53) | 13 (36) | 59 (48) | |
| Stage | ||||
| I | 18 (21) | 12 (33) | 30 (24) | 0.21 |
| II | 53 (61) | 16 (45) | 69 (56) | |
| III | 16 (18) | 8 (22) | 24 (20) | |
| Grade | ||||
| I/II | 9 (11) | 4 (12) | 13 (11) | 0.99 |
| III | 73 (89) | 30 (88) | 103 (89) | |
| Surgery | ||||
| Mastectomy | 41 (47) | 22 (61) | 63 (51) | 0.17 |
| Lumpectomy | 47 (53) | 14 (39) | 61 (49) | |
| Neo/Adjuvant chemotherapy | 80 (91) | 34 (94) | 114 (92) | 0.7 |
| Yes | 8 (9) | 2 (6) | 10 (8) | |
| No | ||||
| Adjuvant radiotherapy | 57 (65) | 24 (67) | 79 (66) | 0.99 |
| Yes | 31 (35) | 12 (33) | 41 (34) | |
| No | ||||
*
Due to missing data, the numbers for some of the baseline characteristics do not add up to the column totals.